Skip to content
Clinical Trials – home

Clindamycin Hydrochloride: A Comprehensive Guide for Patients

8 / 11
trials open to patients / all trials
17+
Countries

In short

This article examines the use of Clindamycin Hydrochloride in various clinical trials. Clindamycin is an antibiotic used to treat a wide range of bacterial infections. The trials discussed here investigate its effectiveness for conditions like acne, bacterial vaginosis, and other infections, as well as exploring optimal dosing regimens and comparing it to other antibiotics.

At a glance

Conditions Studied
Acne, Bacterial Vaginosis, Septic Abortion, General Bacterial Infections
Administration Methods
Oral capsules, Intravenous injections, Topical gels
Comparison Studies
Clindamycin vs Metronidazole, Clindamycin vs Placebo
Primary Outcomes
Reduction in acne lesions, Eradication of abnormal vaginal flora, Cure rates for septic abortion, Pharmacokinetic parameters (Cmax, AUC)
Special Populations
Pediatric subjects with high BMI, High-risk pregnancies
Combination Therapies
Clindamycin + Adapalene, Clindamycin + Gentamicin

What is Clindamycin Hydrochloride?

Clindamycin Hydrochloride is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called lincosamide antibiotics. Clindamycin works by stopping the growth of bacteria, helping your body's immune system fight off the infection.

This medication is also known by other names, including:

  • Clindamycin phosphate (when given intravenously)
  • Clindamycin palmitate (when given as an oral solution)

These different forms allow doctors to prescribe the medication in various ways depending on the patient's needs and the type of infection being treated.

What Conditions Does Clindamycin Treat?

Clindamycin is used to treat a wide range of bacterial infections. Some of the conditions it can help with include:

  • Osteoarticular infections: These are infections in the bones and joints, often caused by bacteria like Staphylococcus aureus.
  • Acne: Clindamycin is sometimes used in combination with other medications to treat severe acne.
  • Bacterial vaginosis: This is an infection in the vagina caused by an overgrowth of certain bacteria.
  • Other bacterial infections: Clindamycin can be used to treat various other infections throughout the body, depending on the type of bacteria causing the infection.

How is Clindamycin Administered?

Clindamycin can be given in several ways, depending on the type and severity of the infection:

  • Oral capsules: These are swallowed and typically contain 300 mg of clindamycin.
  • Intravenous (IV) injection: This method is often used for more severe infections or when patients can't take oral medications.
  • Topical gel or cream: This form is often used for treating acne.
  • Oral solution: This liquid form is sometimes used, especially for children or those who have difficulty swallowing capsules.

Dosage Information

The dosage of clindamycin can vary widely depending on the type of infection, the patient's age, weight, and overall health. Here are some general guidelines:

  • For adults, a typical oral dose is 300 mg every 6 to 8 hours.
  • For children, the dose is often calculated based on body weight. A common range is 30-40 mg per kg of body weight per day, divided into 3 or 4 doses.
  • For severe infections, higher doses may be used, but typically not exceeding 2.7 grams per day for adults.

Always follow your doctor's instructions regarding dosage and timing of medication.

Effectiveness of Clindamycin

Clindamycin has been shown to be effective against many types of bacterial infections. It's particularly useful for:

  • Treating infections caused by Staphylococcus aureus, including some strains that are resistant to other antibiotics.
  • Fighting bacteria that form biofilms (layers of bacteria that stick to surfaces in the body and are hard to treat).
  • Penetrating well into bones and joints, making it effective for treating bone and joint infections.

Potential Side Effects

Like all medications, clindamycin can cause side effects. Some potential side effects include:

  • Diarrhea
  • Nausea or vomiting
  • Skin rash or itching
  • In rare cases, a severe intestinal condition called pseudomembranous colitis

If you experience severe or persistent side effects, contact your healthcare provider immediately.

Use in Special Populations

Clindamycin's use may need to be adjusted for certain groups of people:

  • Children: Dosage is typically based on body weight.
  • Overweight or obese individuals: Some research is being done to understand if dosing needs to be adjusted for people with higher body mass indexes (BMIs).
  • Pregnant or breastfeeding women: Always consult with a healthcare provider before using any medication during pregnancy or while breastfeeding.

Ongoing Research

Researchers continue to study clindamycin to understand how to use it most effectively. Some areas of current research include:

  • Combining clindamycin with other medications to treat acne.
  • Understanding how obesity affects the way the body processes clindamycin.
  • Comparing different forms of clindamycin (like capsules vs. liquid) to see if they're equally effective.

As with any medication, it's important to use clindamycin only as prescribed by your healthcare provider. Always complete the full course of antibiotics, even if you start feeling better, to ensure the infection is fully treated and to help prevent antibiotic resistance.

Questions people often ask

Conditions where Clindamycin Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Clindamycin Hydrochloride

Recruiting trials first

See all 11 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).